BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 18207706)

  • 41. Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity.
    Hill AP; Young RJ
    Drug Discov Today; 2010 Aug; 15(15-16):648-55. PubMed ID: 20570751
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In silico approaches to prediction of aqueous and DMSO solubility of drug-like compounds: trends, problems and solutions.
    Balakin KV; Savchuk NP; Tetko IV
    Curr Med Chem; 2006; 13(2):223-41. PubMed ID: 16472214
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Solubility measurement of polymorphic compounds via the pH-metric titration technique.
    Fioritto AF; Bhattachar SN; Wesley JA
    Int J Pharm; 2007 Feb; 330(1-2):105-13. PubMed ID: 17049191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Canine intestinal contents vs. simulated media for the assessment of solubility of two weak bases in the human small intestinal contents.
    Kalantzi L; Persson E; Polentarutti B; Abrahamsson B; Goumas K; Dressman JB; Reppas C
    Pharm Res; 2006 Jun; 23(6):1373-81. PubMed ID: 16715357
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New QSPR study for the prediction of aqueous solubility of drug-like compounds.
    Duchowicz PR; Talevi A; Bruno-Blanch LE; Castro EA
    Bioorg Med Chem; 2008 Sep; 16(17):7944-55. PubMed ID: 18701302
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High throughput screening of CO2 solubility in aqueous monoamine solutions.
    Porcheron F; Gibert A; Mougin P; Wender A
    Environ Sci Technol; 2011 Mar; 45(6):2486-92. PubMed ID: 21341690
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aqueous solubility and true solutions.
    Loftsson T
    Pharmazie; 2010 Jun; 65(6):404-7. PubMed ID: 20614686
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Setup and validation of shake-flask procedures for the determination of partition coefficients (logD) from low drug amounts.
    Andrés A; Rosés M; Ràfols C; Bosch E; Espinosa S; Segarra V; Huerta JM
    Eur J Pharm Sci; 2015 Aug; 76():181-91. PubMed ID: 25968358
    [TBL] [Abstract][Full Text] [Related]  

  • 49. pKa and solubility of drugs in water, ethanol, and 1-octanol.
    Domańska U; Pobudkowska A; Pelczarska A; Gierycz P
    J Phys Chem B; 2009 Jul; 113(26):8941-7. PubMed ID: 19518053
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The influence of aqueous content in small scale salt screening--improving hit rate for weakly basic, low solubility drugs.
    Tarsa PB; Towler CS; Woollam G; Berghausen J
    Eur J Pharm Sci; 2010 Sep; 41(1):23-30. PubMed ID: 20553863
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Solubility of drugs in aqueous solutions. Part 5. Thermodynamic consistency test for the solubility data.
    Ruckenstein E; Shulgin I
    Int J Pharm; 2005 Mar; 292(1-2):87-94. PubMed ID: 15725556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biorelevant solubility of poorly soluble drugs: rivaroxaban, furosemide, papaverine and niflumic acid.
    Takács-Novák K; Szőke V; Völgyi G; Horváth P; Ambrus R; Szabó-Révész P
    J Pharm Biomed Anal; 2013 Sep; 83():279-85. PubMed ID: 23770783
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of biorelevant simulated media mimicking the intestinal environment to assess the solubility profiles of poorly soluble drugs.
    Prasad D; Gu CH; Kuldipkumar A
    Pharm Dev Technol; 2016; 21(4):511-7. PubMed ID: 25703029
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High throughput solubility measurement in drug discovery and development.
    Alsenz J; Kansy M
    Adv Drug Deliv Rev; 2007 Jul; 59(7):546-67. PubMed ID: 17604872
    [TBL] [Abstract][Full Text] [Related]  

  • 55. UV-spectrophotometric determination of imatinib mesylate and its application in solubility studies.
    Bende G; Kollipara S; Sekar V; Saha R
    Pharmazie; 2008 Sep; 63(9):641-5. PubMed ID: 18819515
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In silico prediction of drug solubility: 4. Will simple potentials suffice?
    Lüder K; Lindfors L; Westergren J; Nordholm S; Persson R; Pedersen M
    J Comput Chem; 2009 Sep; 30(12):1859-71. PubMed ID: 19115279
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Crystallization from Supersaturated Solutions: Role of Lecithin and Composite Simulated Intestinal Fluid.
    Indulkar AS; Gao Y; Raina SA; Zhang GGZ; Taylor LS
    Pharm Res; 2018 Jun; 35(8):158. PubMed ID: 29916053
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel approach to determine water content in DMSO for a compound collection repository.
    Semin DJ; Malone TJ; Paley MT; Woods PW
    J Biomol Screen; 2005 Sep; 10(6):568-72. PubMed ID: 16103417
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro solubility assays in drug discovery.
    Kerns EH; Di L; Carter GT
    Curr Drug Metab; 2008 Nov; 9(9):879-85. PubMed ID: 18991584
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Development of solubility screening methods in drug discovery].
    Sugaya Y; Yoshiba T; Kajima T; Ishihama Y
    Yakugaku Zasshi; 2002 Mar; 122(3):237-46. PubMed ID: 11905048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.